Sign In
Buy BVNKF
$27.69
+0 (+0%)
At Close: Jul 31, 2026
Bavarian Nordic sees potential to ramp up mpox vaccine capacity
05:22am, Thursday, 12'th Sep 2024
Bavarian Nordic said on Thursday it could supply 13 million doses of its mpox vaccine by the end of 2025, up from a previous forecast of 10 million doses, and is exploring options to significantly exp
First Doses of Bavarian Nordic's Mpox Vaccine Now Arriving in the Democratic Republic of Congo
07:19am, Thursday, 05'th Sep 2024
COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the first doses of its mpox vaccine, MVA-BN®, also known as JYNNEOS®, has arrived today in the Democra
Undercovered Dozen: Delcath Systems, Bavarian Nordic, Tempus AI, Journey Energy +
03:30pm, Friday, 23'rd Aug 2024
In this article, Seeking Alpha editors highlight 12 ideas published last week focused on stocks with less coverage on our platform. Energy ideas are prevalent in this edition with articles highlighted
COPENHAGEN, Denmark, August 23, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company's shares/related securities by persons holding m
Mpox vaccine maker Bavarian Nordic's stock jumps 10% as European country places jumbo order for doses
02:13pm, Thursday, 22'nd Aug 2024
Bavarian Nordic's stock soared 10% on Thursday after the Danish biotech company posted better-than-expected second-quarter earnings and unveiled an order for 440,000 doses of smallpox and mpox vaccine
Bavarian Nordic Stock Jumps on Revenue Beat, Mpox Vaccine Order
09:55am, Thursday, 22'nd Aug 2024
Shares of Bavarian Nordic are surging 12% in Danish trading after the company with the only approved mpox vaccine in the U.S. and Europe posted a quarterly revenue beat and announced a huge vaccine
Mpox Vaccine Maker Bavarian Nordic Shares Soar Amid Concern Over Virus Outbreak
07:31am, Thursday, 22'nd Aug 2024
Shares of Danish biotech Bavarian Nordic surged on Thursday after the company reported strong earnings and a large order of its mpox vaccine, extending its gains this year as nations mobilize to comba
Bavarian Nordic shares pop over 12% on earnings beat, bumper mpox vaccine order
04:24am, Thursday, 22'nd Aug 2024
Shares of Danish biotech company Bavarian Nordic jumped in early deals Thursday after reporting first-half earnings and a bumper mpox vaccine order.
Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country
01:30pm, Wednesday, 21'st Aug 2024
COPENHAGEN, Denmark, August 21, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract of 440,000 doses to supply its MVA-BN® smallpox/mpox vaccine to an undisclosed Europea
Bavarian Nordic will decide this week on mpox vaccine ramp up, CEO says
08:42am, Tuesday, 20'th Aug 2024
Danish biotech firm Bavarian Nordic is considering ramping up production of its mpox vaccine without having orders lined up, based on talks this week with the World Health Organisation, the company's
Bavarian Nordic: Jynneos Expansion Amid Global Health Emergencies
09:00am, Sunday, 18'th Aug 2024
Bavarian Nordic specializes in vaccines for infectious diseases and immuno-oncology therapies, with Jynneos being a featured vaccine. Jynneos, Bavarian's vaccine for smallpox and monkeypox, is the onl
Bavarian Nordic to ramp up production of mpox vaccine
07:39am, Saturday, 17'th Aug 2024
Danish biotech firm Bavarian Nordic said on Saturday it plans to ramp up production of its mpox vaccine and is working closely with all stakeholders to ensure fair access to the vaccine as mpox has be
Bavarian Nordic seeks 'critical' mpox vaccine approval for teens, CEO says
10:00am, Friday, 16'th Aug 2024
Bavarian Nordic CEO Paul Chaplin discusses how expanded approval for its mpox vaccine could help groups most vulnerable to the latest mpox virus outbreak.
Bavarian Nordic shares up 45% this week on mpox outbreak
07:19am, Friday, 16'th Aug 2024
Biotech firm Bavarian Nordic shares soared over 15% on Friday, another day of substantial gains which analysts have linked to the outbreak of the mpox virus.
Mpox vaccine maker Bavarian Nordic seeks ‘critical' EU approval for teens after WHO declares health emergency
07:14am, Friday, 16'th Aug 2024
Danish biotech company Bavarian Nordic said Friday that it had submitted data to the Europe Union's drug regulator to extend the use of its mpox vaccine for teenagers. CEO Paul Chaplin told CNBC that
